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ABSTRACT The thymus leukemia (TL) antigens, encoded
by class I genes in the Tla subregion of the major histocom-
patibility complex (MHC), are cell surface molecules expressed
on thymocytes of certain strains of mice and on certain T-cell
leukemias. In order to study the fine structure and interrela-
tionships of genes of the TM subregion, a Tla-specific probe was
isolated from the TL-encoding T13C gene ofBALB/c mice (Tb"
haplotype). The probe hybridized with two Tla genes in the Thf
haplotype (T13C and T3C) and with only one in the Tlab
haplotype (T3b). Examination of this subset of Tla genes (T3b,
T3Y, and T13c) by restriction enzyme analysis and oligonucle-
otide hybridization studies confirmed that T3b is the allele of
T3C and that T3Y and T13c may have arisen by duplication. The
T3b gene, while not transcribed in the tissues of the TL- strain
C57BL6, was shown to be transcriptionally active in the
TL-expressing leukemic cell line ERLD derived from that
strain. The T3b gene was cloned and its complete DNA sequence
was determined. These data permit complete comparison of
two Tla-region genes, T3b and its homologue T13c, and allow us
to conclude that these genes show extraordinarily high se-
quence conservation, in contrast to alleles of the H-2K- and
H-2D-region genes. Comparison of T3b with other class I
sequences in the H-2 and Qa subregions suggests that the
T3-subset genes are the most divergent from other class I genes.
The major histocompatibility complex (MHC) class I genes
are a multigene group containing the H-2 genes (K, D, and L),
the Qa genes, and the Tla genes. The number ofgenes in each
subregion varies according to the haplotype, from 2 to 4 for
the H-2 subregion, 8 to 10 for the Qa subregion, and 13 to 18
for the Tla subregion (1, 2). These genes have a number of
features that distinguish them. The H-2 gene system, in
particular the K and D genes and to a smaller extent the L
gene, is marked by an extreme polymorphism (>50 alleles per
locus; ref. 3) and diversity (15-20o differences in alleles)
possibly associated with the role of the products in guiding T
lymphocytes to react to cells bearing foreign antigens. On the
other hand, those products of the Tla and Qa subregions that
have been studied are significantly less polymorphic [e.g.,
only 6 alleles of Tla have been described (Tlaa-; ref. 4)]. In
addition, unlike the H-2 products which are expressed on all
nucleated cells, the TL and Qa products have a more restricted
tissue distribution. The functions ofthe products of the Tla and
Qa genes are unknown.
To study the features of a specific gene (and its product) in
the Tla subregion, we have cloned and determined the
nucleotide sequence of the T3b gene,¶ which encodes a
putative TL protein from the Tlab haplotype. The availability
of this sequence allows the comparison of this gene to Tla
genes of the Tlac haplotype, as well as to other class I genes,
and refines our understanding of the interrelationships of the
class I gene group.
MATERIALS AND METHODS
Mice and Cell Lines. Mice were obtained from The Jackson
Laboratory (C57BL, A, BALB/c, 129); from L. Flaherty
(Albany, NY) (A.CA, B6.AC2-Tlad, B6.AC1) or from Me-
morial Sloan-Kettering Cancer Center (B6.K1, B6.K2,
C57BR-Gix(+), A-Tlab). The H-2, Qa, and Tla haplotypes of
each strain are shown in Fig. 1. The TL-expressing ERLD
leukemia cell line, which was induced in the C57BL strain,
was kindly provided by E. Stockert (New York, NY).
DNA and RNA Preparation and Analyses. DNA was pre-
pared from spleen cells as described (5). Restriction enzymes
were used under the conditions specified by the supplier
(Bethesda Research Laboratories). Digested DNA was elec-
trophoresed in agarose gels and transferred to GeneScreen
(New England Nuclear) (6). Whole-cell RNA was prepared
from fresh tissues as described by Auffray and Rougeon (7).
RNA was size-fractionated in agarose/formaldehyde gels
and transferred to nitrocellulose. The filters were hybridized,
washed, and subjected to autoradiography as described (5).
Isolation and 32P-Labeling of Cloned TL Probe. A 0.1-
kilobase (kb) Pst I-Sac I fragment was subcloned from X-17.3
(8) (containing the T13C gene) into pBR322. The recombinant
plasmid was labeled by nick-translation and separated from
unincorporated [a-32P]dGTP as described by Maniatis et al.
(9).
Preparation of TL-Specific Oligonucleotides. Oligonucleo-
tides were chemically synthesized by either the phosphotri-
ester (Bachem Fine Chemicals, City of Hope, CA) or the
phosphoramidite (Applied Biosystems, Foster City, CA)
solid-phase method.
Sequencing of T3b Gene. Fragments of the H10 cosmid (2)
were subcloned in both orientations, using M13 mplO, mpll,
mp18, and mpl9 vectors (Pharmacia). DNA sequencing was
performed according to Sanger et al. (10), using either the
specific M13 primers (Pharmacia) or T3-specific oligonucleo-
tides.
Abbreviation: kb, kilobase(s).$We use terminology (to be described elsewhere) in which the Tla
genes are designated by the letter T, followed by a number referring
to gene position along the chromosome, with a superscript referring
to the Tla haplotype. Thus the previously described gene 17.3A is
called T13C (see Fig. 2).
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RESULTS AND DISCUSSION
Identification and Preparation of the TL-Specific Probe. To
learn more about the interrelationships among Tla genes, we
initiated studies to isolate and sequence a gene coding for a
TL product in the Tlab haplotype. Since peptide map analysis
(11) had shown an extraordinary similarity between TL
products of the Tlab and Tiac haplotypes, and a DNA
fragment that expressed a Tiac (T13) product was available
(12), we subcloned from that DNA a 0.1-kb Pst I-Sac I
fragment from the 3' end of exon III (designated pTL). This
probe was specific for the Tla subregion and hybridized to a
subset of Tla genes when genomic DNA from a panel of
inbred and recombinant mouse strains (Fig. 1) was examined.
The pTL probe was shown to be a single-copy probe for the
Tlab haplotype, as it hybridized to a single Bgl II restriction
enzyme fragment in C57BL DNA (Fig. 1). Similar results
were obtained using BamHI, EcoRI, HindIIl, Sma I, andXba
I restriction endonucleases (data not shown).
The TL Probe Detects the T3b Gene. A panel of cosmids
containing 26 class I genes spanning the H-2, Qa, and Tla
subregions of C57BL mice (2) was screened with pTL (data
not shown). Only the T3b gene from the H10 cosmid clone
hybridizes with pTL, consistent with the finding that pTL
hybridizes to a single gene in C57BL genomic DNA (Fig. 1).
Interrelationships of the Subset of Genes Resembling T3.
The pattern of hybridization of the pTL probe with genomic
DNA (Fig. 1) revealed different numbers of genes for differ-
ent Tla haplotypes. For example, Tlab had one band, both
Tlac and Tlkhad two bands, and both Tlaa and Tiad had three
bands. The finding of different numbers of genes resembling
T3 in the various haplotypes is consistent with previous
results (8) in which Tla subregions of the Tiac and Tlab
haplotypes were aligned on the basis of restriction endonu-
clease maps (Fig. 2A). In that comparison, T13C was found to
have no allele in Tlab because it resided on a cluster of genes,
TJc'-TJ7c, that was not present in the C57BL mouse.
Since T3b and T3C share all Kpn I and EcoRI sites, and T13C
lacks one EcoRI site and has additional Xba I and Sma I sites
(Fig. 2B), our data indicate that T3b is the allele of T3C and not
the allele of T13c, thus confirming the alignment shown in Fig.
2A. Further support for the close relationship of T3b and T3C
as compared to T13C comes from hybridization analyses with
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FIG. 1. Hybridization analyses using the pTL probe. Character-
ization ofBgl II genomic restriction fragments by hybridization to the
pTL probe shows that the sequences map to the TL region and
identifies a single band for TIab strains. Each lane contains 20 ,ug of
digested DNA. X phage DNA digested with HindIlI endonuclease
was included as size marker; the position and size (in kb) of the
fragments are shown at right. The H-2, Qa, and Tla haplotypes are
indicated below each lane.
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FiG. 2. Interrelationships of Tla genes. (A) Diagram of the
organization of the Tla subregion in BALB/c and C57BL mice,
adapted from ref. 13. Numbered vertical bars indicate each locus
(e.g., 3 for T3). Genes in the Tlab subregion corresponding to
T11C-T18c are absent. (B) Restriction enzyme map comparison of
members of the T3 subset. Digestions and fragment separations were
performed according to Maniatis et al. (9). T3b is more similar to T3C
than to T13c. See text for discussion.
six T3b-specific oligonucleotides (see Fig. 4) prepared from
sequence differences between T3b and T13c, which showed
that T3b and T3C shared all of these sequences (data not
shown). Although T3b and T3c seem most alike, T13C is clearly
homologous to these genes. This finding is consistent with the
idea that T3C and T13C arose by duplication.
T3b Is Transcribed in ERLD. Unlike the H-2 antigens,
which are expressed on virtually all nucleated cells, the TL
products have a more restricted tissue distribution; i.e.,
thymocytes of certain strains of mice (designated TL+
strains), certain leukemias of both TL+ and TL- strains, and
activated T lymphocytes (4, 13, 14). The pTL probe detected
anmRNA species from the polyadenylylated fraction ofRNA
from the TL-expressing ERLD leukemia cell line, but not
from thymocytes of the TL- strain C57BL (Fig. 3). The pTL
probe also hybridized to polyadenylylated RNA from
thymocytes ofTL+ strains (A, BALB/c, 129) but not to RNA
from other tissues (brain, liver, kidney, spleen) of these
strains (data not shown). This pattern correlated with the
reported expression of TL antigens in different tissues (4).
The several different mRNA species that are transcribed in
the TL-expressing leukemia ERLD must all be from T3b (Fig.
3) because this is the only gene recognized by pTL in the
genomic DNA of C57BL tissues and ERLD (Fig. 1). These
bands were not detected in the poly(A)- fraction from ERLD
(Fig. 3, lane D).
Structure of the T3b Gene. The T3b gene from the C57BL
cosmid identified by the pTL probe was subcloned into M13
for DNA sequencing. The sequence of the entire gene
included in a 5.2-kb stretch ofDNA is shown in Fig. 4, which
also presents a comparison to the TJ3C gene, the only other
completely sequenced Tla gene.
The T3b gene contains six exons homologous to the first six
exons of other class I genes (Fig. 4). The 5' flanking region
of T3b contains regions corresponding to the TATAAA and
CCAAT sequences of the RNA polymerase II promoters
(15). The first ATG encountered 3' of the "TATAAA box"
serves as the initiation codon. The sequences neighboring
A B C D
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FIG. 3. Hybridization analysis of
RNA blots shows that the TL probe
hybridizes to RNA from TL+ leukemia
-28S ERLD but not to RNA from C57BL(TL-) thymocytes. Lanes: A, poly(A)+
-18S RNA of C57BL thymus; B, poly(A)-
RNA of C57BL thymus; C, poly(A)+
RNA of ERLD; D, poly(A)- RNA of
ERLD. Five micrograms of RNA was
used per lane. 18S and 28S rRNA posi-
tions are indicated.
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this region agree with the consensus sequences for transla-
tional initiation sites, namely an A in position -3 and C in
positions -1 and -5 (16). A change in the position of the
initiation codon to 15 nucleotides 5' of the conventional class
I initiation site creates a signal peptide that is five amino acids
longer than that of other class I molecules.
Exons II-V correspond both in sequence and in the
position of intron-exon borders to other class I sequences. In
contrast, whereas murine class I cytoplasmic domains are
encoded by three exons, VI-VIII, the putative cytoplasmic
regions of both T3b and T13C may be entirely encoded by the
sixth exon. However, the cytoplasmic portion of T3b appears
to be 23 amino acids longer than that of T13C because of the
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insertion of two nucleotides prior to the translational termi-
nation (UGA) codon identified for T13c. There is a region 3'
of the termination codon in exon 6 for both genes that shares
homology with exon VII of other class I genes. The function
of this region is not understood.
Another unique feature ofthe T3b and TJ3C genes is a 1.1-kb
insertional sequence in the third intron, flanked by a 10-base-
pair inverted inexact repeat (Fig. 4). This insert begins with
a repetitive T-rich tract and ends with a B2 Alu-family
repeated sequence (17). This stretch is highly conserved in
both the T3b and T13C genes. To our knowledge, T3b and T13C
are the only class I genes known so far to contain this 1.1-kb
insert.
T3 b 1 ggtcgtatctatacactcaggttcagtgcagaagaaggag tcagqacaaaqttccaagtcccaagtcccggaagtggctg tcagggtctgagectgaaggcgqgggqattagjqttgqget9 taccagaactatagtttcactttttqctctTI3c 1 ---------------tc------------------------------------------------------------------
EXONf1 M R M G T P
151 ctg taccattgtcagattgttttcaaaggccttgcactcctg tcgagagcagg tacttagaaga caaaaactctctqagattgcaag ttacaaag tccacgactttatacaattcaatttcctaacATc GGATCGAMCACACC
89 ---------------e-
------------------c--------------------- ----------a----------------q---c------------------------A
0
V P G T L L I L L A A S 0) G O T 0 T C O
301 AGIXXXr"ACCClCTGATCCTC ll^C AGKCAACAGACCCAGACC7 CCC~~tgag tqctqga tgaggagggaaacagcct tttaggggagqgggcgaqggtccaccctccaccagaccctccaccac ttctccactcaa
239 -----A-C ------C--------------------T-----------------
_-------------t----------- ------------------
S--- - - P
EXON2 G S H S L R Y F Y T A L S R P A r s E P
451 ggeccctagacctgagtccttctacr-tccctg tcctgcgcacctggccggg ttctgggagaaggtcacag tctcaccaca tgec tcccccagGCwrACACTCGClrA(3GACltrTACACCGCcTrClC(Clo AAT AGCGA.ACCG
389 ------------------------------g9----a----ct--- ------------9- -- ,gg-----------gc---g------- ------------- ------------------------- ------------------ --A
W Y I A V G Y L D D T Q t' V R F N S S G E T G T Y K( L S A P W V E O E G P E Y W A R E T E I V T S N
601 OAIIlwlAACAGCICAa3GGAGACfTGCGACATATAAGCTAAGTCGCCATGG3GIC'.AAAGAG(;GGCCCAArATTTZGCGAGGAGGACAGAC-ATCGTC ACAAGCAAT
539 --C--- -- - - - ---C--G- ---------- ---------------------------- -------- -----
- - - - - - - - - - - - - A --D - A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
A Q F F R E N L Q T M L D Y Y N L S Q N
751 GlSAAGlqTUCCGCGAGAATCrnCAGACTAlGTlGCTACTACAACCTGAGTCAAAAT()gtgaggaaccccccaaatctaagag tctg tccccac tcctctccctc ttatgcaagccacetaatcatggggtgcaaaaqggac tgqct
EXR3 G S H T I O V M Y G C E V E F F G S L F R A Y R O H G Y D G R
901 rccctttcag tttggagaattcc tagggt999c999cctgactaggagagggqgqccagGClNCWACACCATCCAGGI GA7ATSTAl-elGM3GAGlM~lSGAGAGCcv C(XlbrCATrAbGCA(GClnt rAlrATl-iIc
839
-------__________----------------t---t ----------------------------------------------------------------------------------------------------------- =AA
D Y I A L N E D L K T W T A A D T A A E I T R S R W E O A G Y T E L R R T Y L E G P C K D S L L R Y
1051 GA7TACATIICCCIM ^ACACG;AACGA Al>GCAGPACACA TCACCGAAGCAAGrGCOA(G~tCATACAGA(;CTCCGTAGGACCTA.C ~lGGAOCCCA7K CAAGG;ATIlCTGAGATAC
989 -------C--------------------------------
--------------------------------------------------A----A-------------------------------------
- - - - - - - - - M - - - - - - - -
-_
L E N R K K T Q E C T
1201 CTGGAGAACACAAAGAACACACAGrCACA
1139- - --- _______-. --
1351 tttttgtttgcttgtttgqttggqtttttttgtt
1289
-g
1501 aacatgaattttacatattctccattaaatata
1439 g-t---p--
1651 gagaaccagtggcagaattagaagtagctatcd
1589 a- -----------------------
Iactcatgctatccaacatcgacccagggqgtcagqgcagqagaqagaacagagactgagactcacagaacacgagaqacagaqgqcaqaq cagaaaqagatqqaqaqacagaaac qa
*--------------------------------------------------------a---------------------------------q------------------------ a--
cattcttaacaagta
1739
-- .--------g_
tacgtttttttg tttcttttg ttgttattttg tttg tttqttttgctaaattacctctatgagcaaaaaagactgcag ttttacttcctgttgtttttqaattgqt gacttcqtttaatattqtatat
1951 tcaaagttcatcaattttcctagataatqtgtgtattacattqtgtagtgctcaacaggattccactttatatatataccacatttt gttagtcacttaaqtgaataataggttqctttactgcaatagctaagatqtcacactccata
1889
--------------------------------------------a-----------------------------c---a--c ------------------------------ ----------c------------
2101 tcaaggaagagag tagagagtgg acagttcttt ccttctttttttttaaagatttatttatttatttatttattatacatagt ac gtagcttcttcagacacaccgaqaggtgtcggtctcattacaggtqqatq
2039
---tt----------------c---------ccttctctcttt------------- -- ---------------- --- --
-c-tta---a--t----------------agnq---a-----------.a--t--
2251 tga~gccaccatatggttgagqgaatettgaactcag taccttcgaaga~gcaatcagtgtccttacccg ttgagccatctcaccagccctgg tgtcttgtatctat acgatactggg tqtctcttcatttgacacaat
2189--- ----ct----------g--------- ---a -------- --------- ---------_g_________------------- a------------t---q
2401 gttccagcctcttcag tgttcc tttctcttcaatacggg-aaggggagagaactcctgtg tttcttgactctctcagagactggctctcccaagggacgcaccttfrg tctc tggacag ttcagagtctcttcaggpatgaaaaggqagaagag
2489 -a---------nnn--------------------g ------------------------------------- ----------------ac------ac------
---ag-g--------
2551
-- ac- a aa-
2639
-
-g--- ------. a-- -t-ta--- .- -a-- ------- .-
EM0N4 D P P K T H V T H H P R P E G Y V T L R C W A L R F Y P A D I T L T W
2851 accaigagaaa~gatatttgatgcccaaacrtttccaactcttctccctcagATcCCCCAAAAAACAClorACCCrACCCCACACrI quAIACCCWAGCATCCAGACCrrGCGCiT"CCCrrATCATClACVClSkC
2789 -a------------a-------.---------------------------------------------- --------------G -----------G-----------------------C---------------
- - - - - - - - - - A - - - - D - - - - - - - - G - - - - H - - - - -
Q L N G E E L I Q D T E L V E T R P A G D G T F 0 K W A A V V V P L G K E 0 K Y T C H V Y H E C L P
3001 GCAMI 7OGAG~A.T1GATrCAm7ACACG GAGC~GG~GCAccGOCClAGG3O~ GAlACCTlCAGRA~rAGCA~r(:l rGGlrCCGCTAGmG7Aa AGAAATACAA7CAqff~rtslrACCA7GAG ccrG
2939 -------------------------------------------------------------------------------------------------- 7qr---G-A
---------------
----------------------
- - - - - - - - - - S - E - - - - - - -
E P L T L R W
3151 TGAGCMCCCTAAOgteaa, ggagggtgtgggtgca~gagctgggg tcagggaaagctggagccttctgaag accctcagctgg tcagaqttggqa, gttgagatcatg ttgctcattttcccctcctg tccttacccttccct t
3089 -------------------------------------------------------------------------------------------t---a------c--------------c------a--a------------------
EXDN5E P P O T S M P N R T T V R A L L G A M I I L G. F M S G S V M M W M R K N N
3301 cccagAC~CIICCGAGrA TGCoCAACAACC;IMAGGI=AItcGAGCGckT6'r~rTAAarA7rGG~klT.AAGGA.CAA'g tatgqaagag tctgtgqctgqq tqccttat
323---9 -------------_-----_-----______________________________________________-------------------------------____________w___
S -
-
3451 gattgtaaaccaatacacatgcactctatgcaaaagaattgcc tatctctgqggtctg tttgcagacactcaccttacaataaaagacagattcataatggtaatog .9 ttctgcacgagcattctaaatagcctctcagagqtcagaqq
3389 ------------------- --------------- --------------------------------------------------------------------- q-------- --q-------a----------a-ag--
FIG. 4. (Figure continues on the next page)
'AGgttcg tggctqcagacaactccatctccctttqcctctq tactqqgttcag tccagagagaqcagaaac tcactaggtqgiaaaactcccatc.ctttttcttttttctttttq ta
:tttttaattttaaaagg cgacaacagaaaaataacqtatgaaaattacacaaaccaatgqctatacacagctcag tqagcttq taaacag ttagaatcgccactttgqaccag taq aq
Proc. Natl. Acad. Sci. USA 83 (1986) 1785
E1XN6 G G N G D D N T A A Y
gcaagtca-gc taaacacract atctccagtgcC~t tg t tccaccccctgcatataatgtccatggcacagaac ttccttgg ttctcatatct ttt ttt tt tt aaacaaGrAAACGACGATAACACrlC3GCATAAr3601
3539
Q N E R E H L S L D P R A F S H A L G V E A G M K D L P S A P H L V S X f
375S1 AGAATGAGAG GACACTrl. ClrACCCTGGArerCTC~rACG3CA CTCM GCTGOA7GAmAG;GATCTrCFK CCCCACACCrC-rC-IrCAcaatg tctt ttacttcttctactgcaggcaaqqacagcttc t
3689 ------------------ -T---- -'-- ---a --------------- ------- . ca--- -------------------------- ----.----------------
- T S G X
3901 crctr-gtc tcr-ggaraccr-gaaaaggegacacctgggagcctg-ggar tgqgggtgaggcaaactggaaaggactgggtcac tgggcctttcatatttaaacctttgaacgagagqaaggcctttgagatg ttttcacattgactgccctg
3839 g-------------g----------------------- -----------------------'--c-------t---~--------a------------t-------a-------------------------------
4051 actcCtg ccc cca cc tgqgacagc tgccacatqqggactg9ag tcacaag ttcrg9acttctg aacag tggaatcactttgggcageeg tgectgc ttttatgctttt-gactatqcatacatgqqaaaatctgg~a~gagcacagcctgeccc
3989 -----t------c------------------------------------------------------a----------------a--t--- t----------------gq------------t------------------------
4201 cr-gcacaccaagactcagaccccacat tagectg tcatcccttgcacagccaaccttcctgqgtcctaggcattgggggacatcttcatcctgtcagctccacgctg tcctgqqgcqtgtg tctcctcacacgggacag tq tgttactcat
4139 --------------------------------a --------------------------------c-------- -----~~----------------------------a&-c----------------cc----a---c------
4 351 ttccacacag aacargagaatctgaatg tggatg tcaqqcag tqg tqgcgaggccat taatcc tagcacattgggaggcagaggcaggcaqag ttctgag ttcgagggcagcctqggtttacag ag tgag ttccaggacag acagggctac
4289 --------t------ ------------------- --- --------tg------------_______ ----------------------t--------------c---------c----a---- -----------c,---------
4501 acagagcaactceta rcctt99ggggaaaaaaaag ac a gaaa 9aaaaaaaaa gaatc tgaatg tqgagjgctggagag aag tctcag tqgttg taagagc ac tqagcttcttttcctg aggccctg aattcaatccccag
44 39 -----a--t---- t------ --------ca-- a-gg---- aaa----------aaaa----------------------- p-y-q----------- ---c --t----ct---- ------a-----t------------
46 51 caaccaca tgg t gctcacaaccata t9 taatagcatgcaa tg cttctrctgg9 tgtr-ggaag tcacc tacag tg tactcacctacatgiatacgaatc ttaagaaaag tatg ag tg taactccttqacctgagcag ttcactt
4 589 --- ----g ---- -c--- -c- c-----c-
-g- a----- t--- --------
4801 gtgggtaaac taaagg attgagaatatctgagtattgrcggaggaaataaatggcagcatggaggacct~ccagaatctg tgtttcttg tgctgagtq tgtcaggtgg qcaggag tcctietgcatctqcq tgtaatqgsctqtgecag
4739 ----------t--------g--------t-a--------------------t -----------------------------------a----------gq----------------------t-------------------
4951 9 tggagctcag tccaatgg aaag tccctgcr-ggr-cagg tc attccr-cagctatacctctgtgg tacttg tcacttaatagag tcactg at-gacagactctgatcttaqggtagqaacacagc atggccttagcocccc taag ttg tac
4889 --------------9tg-c-c---- t-------- t----q------------------------------------------------ q--------------- qa- ---- ---- -aa--- -------c--------------
5101 taggcccgr-agr-gcagccgagaaactgacar taccag tgaag aaatcttggaag agtgg c99 ccaacacatttaatcccaacattcaggagacagacaag aaccar-tgatttccaggccatcctggacactcaggg tgacacagagaa
5039 --------t----------a--------------- t-a-a-------t-g-----a---
-9 -----c------------------------- -g-aa-----c-------t--- ----------------------------
5251 accctg tctccaaac r9g9gtacc
5189 --------------t--------
FIG. 4. Sequence of TVb and comparison with T131. Coding regions for TVb are shown as capital letters with the translated amino acids
(single-letter code) above the DNA sequence. Amino acid changes in T131 are shown under its sequedce. The homo~logous nucleotides for T13c
are represented by dashes, and spaces are inserted to maximize homology. The two possible TATAAA sequences are utnderlined and the CCAAT
sequence is boxed. In the third intron, the two inexact inverted repeats are indicated by horizontal arrows. Near the 3' end of the gene, vertical
arrows indicate possible splice junctions bordering exon 7 and beginning exon 8. The first AATAAA polyadenylylation signal is boxed. The six
TVb oligonucleotide probes specific for differences between the two sequences (see text) are designated *-e.
The 3' untranslated region, starting at the end of the sixth
exon, includes two tandemly arranged Alu-family repeated
sequences, B1 and B2 (18, 17). At the end of the B2 sequence
is the first polyadenylylation site (Fig. 4). Since this
polyadenylylation signal is 800 nucleotides 3' from the
translational termination codon, we expect the transcribed
product of this gene to be about 2.2 kb long. This is consistent
with the detection by hybridization of an 18S band in ERLD
mRNA (Fig. 3). The identification of RNA of larger molec-
ular weight might be accounted for by alternative polyade-
nylylation, as in the case of H-2Ld, in which two effective
polyadenylylation sites also provided by Alu-family se-
quences were found (19). Alternatively, these messages may
represent unprocessed or alternatively spliced products of
this gene. Additional studies are required to distinguish
between these and other possibilities.
The expression of TL in leukemias of TL- strains [e.g.,
ERLD (13)] has suggested that all strains have the structural
sequences for TL but differ with regard to regulatory se-
quences controlling its expression. Our data on the sequence
and organization of T3b suggest that it is a functional gene.
The finding of a T3b transcript in ERLD and the absence of
such a transcript in C57BL thymocytes demonstrate its
ability for differential expression. However, the elements
that control this trait are still unidentified.
Properties of the T3b Protein Inferred from the DNA
Sequence. The T13C gene encodes a TL product of TL.1 and
TL.2 specificity upon DNA-mediated transfer into mouse
fibroblasts (12). The high conservation of amino acid se-
quence between T3b and T13Cproducts (198% identity in the
first two domains; Table 1) suggested to us that T3b encodes
a TL product in ERLD cells of serological specificity similar
to that of the product encoded by T13C in BALB/c
thymocytes. Indeed, TL antigens isolated from BALB/c
thymocytes and ERLD cells share the TL.1, TL.2, and TL.4
specificities (20).
The T3b protein, inferred from the DNA sequence, con-
tains general features that classify it as a class I antigen. Thus,
compared to other class I antigens, the ca1, a2, and a3
domains are of the same length; the cysteines required for the
formation of disulfide bridges are conserved in the a2 and a3
domains; and the a3 domain, thought to bind P2-microglob-
ulin, shows %90% homology with other class I products
(Table 3). On the other hand, the high dissimilarity for regions
other than a3 between T3b and H-2 products may account for
some of their biological differences. Thus the T3b product
differs from the Kb product by 43% in the first domain and
35% in the second domain (Table 3). Whereas Db and Kb
differ from each other in the transmembrane and cytoplasmic
regions to the extent of 25% and 20%, respectively, the
transmembrane and cytoplasmic regions of Kb differ from
those of the T3b product by 53% and 80%. In addition, there
are differences in the leader peptide and glycosylation sites
between T3b and Kb. For example, the change in the initiation
site leads to a T3b signal peptide that is five amino acids longer
than that of Kb and other class I molecules. The leader
peptide also differs from that of Kb by -45% (Table 3). The
only two potential N-linked glycosylation sites are in the al
domain of T3b. This is in contrast to the Kb protein, which is
glycosylated in both the al and a2 domains, and the Db
protein, which is glycosylated in three sites, one in each
Table 1. Percent nucleotide and predicted amino acid divergence
between T3b and T13b and alleles of H-2K
% divergence
T3bvs. T13C Kb vs. Kd
Gene Protein Gene Protein
5' Intron 4 6
Exon I (leader) 7 15 7 5
Intron 1 5 9
Exon II (domain al) 2 3 9 20
Intron 2 2 6
Exon III (domain a2) 2 2 11 19
Intron 3 5 ND
Exon IV (domain a3) 4 7 7 13
Intron 4 5 8
ExonV (TM) 1 3 7 13
Intron 5 3 3
Exons VI-VIII (Cyto) 6 3 9
TM, transmembrane domain; Cyto, cytoplasmic domain; ND, not
determined.
Genetics: Pontarotti et al.
Proc. Natl. Acad. Sci. USA 83 (1986)
Table 2. Percent nucleotide differences (for exons I-VI) between class I genes from C57BL mice
Kb QiOb T3b
I II III IV V VI I II III IV V VI I II III IV V VI
Db 8 12 4 13 0 14 11 3 17 12 30 25 8 35 33
Kb 15 12 13 5 24 12 40 26 25 8 36 34
Q1Ob 40 30 25 8 40 36
Table 3. Percent amino acid differences between class I gene products from C57BL mice
Kb QiOb T3b
L al a2 a3 TM Cyt. L al a2 a3 TM Cyt. L al a2 a3 TM Cyt.
Db 16 21 10 25 20 21 23 9 44 41 10 53 85
Kb 14 18 19 13 45 43 35 11 53 80
QJOb 50 45 36 11
L, leader; al-a3, domains; TM, transmembrane region; Cyt., cytoplasmic region.
domain. Such differences may reflect biological differences
between the H-2 and TL molecules.
Allelic Members ofthe T3 Subset Are Highly Conserved. The
degree of nucleotide sequence conservation between T3b and
T13c, although they are not alleles, is =96% overall. This
represents an extremely high level of homology for class I
genes. When the sequence of T3C is available, we expect the
conservation to be even greater between T3b and T3c, since
restriction maps and oligonucleotide hybridizations suggest a
greater similarity between these two genes (Fig. 2B). On the
other hand, comparison of the K alleles Kb and Kd (21, 22)
shows that these sequences are much less conserved (Table 1).
The contrast in conservation and diversity is even more
striking at the protein level. For example, the al domains of
T3b and T13C show about 3% divergence, compared to 20%
between al domains of Kb and K , and a2 domains show
about 2% divergence between T3b and T13c, compared to
19% between products of K alleles. We would expect such
conservation of protein sequence to relate to the function of
the T3/T13 products, in contrast to the suggested importance
of diversity for the H-2 system, for which the function is
antigen recognition.
Interrelationships of H-2, Qa, and Tia Genes. When exam-
ined for all coding regions, Kb, Db, and Q10b are more
homologous to each other than they are to T3b (Table 2). For
example, the nucleotide divergence of exon III is about 12%
between Kb, Db, and Q10 genes (23) but about 25% between
T3b and either Q10b or Kb. Although only partial sequences
have been published for a number of other class I gene
sequences, comparison of the available data permits further
conclusions about the interrelationships of class I gene
sequences. Thus, comparison of exon III of the Qa genes Q4
ofC57BL (24) and 27.1 ofBALB/c (25), the Tla genes T5 and
T8 (26) of BALB/c and pH37 (27) ofDBA/2 reveal again the
similarity between H-2 and Qa genes, with sequence diver-
gence ranging from 10 to 15% in exon III. However, com-
parison among the partial sequences of Tla genes shows that
the range of divergence among these Tla loci (except for the
homologues T3 and T13) is 30-40% in exon III. Companson
of exon III of Tla genes to exon III of Qa and H-2 genes also
shows a range of divergence of 25-35%. Thus, even though
the complete sequences are not available, we can conclude
that the few Tla loci examined differ from each other at least
as much as they do from H-2 and Qa genes.
Note Added in Proof. Obata et al. (28) have published the sequence
of a TL gene (isolated from ERLD leukemia) that appears to be the
T3b gene.
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